Robert Van-Nostrand, Director at Intra-Cellular Therapies, holds 7.57K shares in Intra-Cellular Therapies (Ticker: ITCI), holds ― shares in SELLAS Life Sciences Group (Ticker: SLS), holds 0.00 shares in Achillion Pharmaceuticals (Ticker: ACHN).
What is the percentage of profitable transactions made by Robert Van-Nostrand?
The percentage of profitable transactions made by Robert Van-Nostrand is 40%.
What is the average return per transaction made by Robert Van-Nostrand?
The average return per transaction made by Robert Van-Nostrand is 32.30%.
What stocks does Robert Van-Nostrand hold?
Robert Van-Nostrand holds: ITCI, SLS, YTEN, ACHN, ENUMQ stocks.
What was Robert Van-Nostrand’s latest transaction?
Robert Van-Nostrand latest transaction was an Uninformative Buy of $7.06K.
What was Robert Van-Nostrand's most profitable transaction?
Robert Van-Nostrand’s most profitable transaction was an Informative Buy of ACHN stock on December 18, 2018. The return on the trade was 216.90%.
What is Robert Van-Nostrand's role in Intra-Cellular Therapies?
Robert Van-Nostrand's role in Intra-Cellular Therapies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.